12-122978910-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000542678.5(ABCB9):c.-100A>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000384 in 1,612,930 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
ENST00000542678.5 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OGFOD2 | NM_001304833.2 | c.689T>A | p.Leu230Gln | missense_variant | 6/7 | ENST00000228922.12 | NP_001291762.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OGFOD2 | ENST00000228922.12 | c.689T>A | p.Leu230Gln | missense_variant | 6/7 | 1 | NM_001304833.2 | ENSP00000228922.7 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152238Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000770 AC: 19AN: 246744Hom.: 0 AF XY: 0.0000668 AC XY: 9AN XY: 134722
GnomAD4 exome AF: 0.0000383 AC: 56AN: 1460692Hom.: 0 Cov.: 31 AF XY: 0.0000385 AC XY: 28AN XY: 726660
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152238Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74374
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 16, 2024 | The c.509T>A (p.L170Q) alteration is located in exon 7 (coding exon 5) of the OGFOD2 gene. This alteration results from a T to A substitution at nucleotide position 509, causing the leucine (L) at amino acid position 170 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at